Victoza Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Condition: Obesity Intervention: Drug: Liraglutide Sponsor: Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Condition: Diabete Type 2 Interventions: Drug: Liraglutide; Drug: Placebo Sponsors: Biolingus; Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2022 Category: Research Source Type: clinical trials

Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
Conditions: Atrial Fibrillation; Recurrence; Overweight and Obesity; Liraglutide Interventions: Drug: Liraglutide plus upstream risk factors modification advice and consultation; Other: Upstream risk factors modification advice and consultation Sponsors: University Hospital Birmingham NHS Foundation Trust; University of Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2022 Category: Research Source Type: clinical trials

A Study in People With Obesity to Test the Effects of Different Doses of BI 456906 Compared With Liraglutide on Glucagon Receptor Activity in the Liver
Condition: Obesity Interventions: Drug: BI 456906; Drug: Liraglutide Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials